Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

778 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Azathioprine: state of the art in inflammatory bowel disease.
Sandborn WJ. Sandborn WJ. Scand J Gastroenterol Suppl. 1998;225:92-9. doi: 10.1080/003655298750027290. Scand J Gastroenterol Suppl. 1998. PMID: 9515759 Review.
Cyclosporine treatment of inflammatory bowel disease.
Sandborn WJ, Tremaine WJ. Sandborn WJ, et al. Mayo Clin Proc. 1992 Oct;67(10):981-90. doi: 10.1016/s0025-6196(12)60930-6. Mayo Clin Proc. 1992. PMID: 1434859 Review.
Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
Sandborn WJ, Hay JE, Porayko MK, Gores GJ, Steers JL, Krom RA, Wiesner RH. Sandborn WJ, et al. Hepatology. 1994 Apr;19(4):925-32. Hepatology. 1994. PMID: 8138267
A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis.
Sandborn WJ, Tremaine WJ, Schroeder KW, Batts KP, Lawson GM, Steiner BL, Harrison JM, Zinsmeister AR. Sandborn WJ, et al. Gastroenterology. 1994 Jun;106(6):1429-35. doi: 10.1016/0016-5085(94)90394-8. Gastroenterology. 1994. PMID: 8194687 Clinical Trial.
778 results
Jump to page
Feedback